ASCO: Double ASCT Beneficial in High-Risk Neuroblastoma
Tandem treatments might give survival edge to children with neuroblastoma
Frailty Prevalence >8 Percent in Young Adult HCT Survivors
Frailty linked to subsequent risk of all-cause mortality after adjustment for confounders
Exercise Cuts Cardiac Events in Non-Metastatic Breast Cancer
Incidence of cardiovascular events down across increasing total MET-h/week categories
ASCO: Adding Daratumumab Early in Myeloma Treatment Efficacious
Response rate doubled for patients with relapsed or refractory multiple myeloma
ASCO: Aggressive Treatment Common in Terminal CA Patients
Three in four of young or middle-aged patients get aggressive therapies in last months of lives
Operative Hysteroscopy Doesn’t Cut Postmenopausal Bleeding
No significant reduction in recurrent bleeding for women with postmenopausal bleeding
125I Brachytherapy Ups Anastomotic Leakage in Rectal CA
Intraoperative implantation increases risk of AL, fecal incontinence, urinary dysfunction
ASCO: Immunotherapy Beneficial in Advanced Bladder Cancer
About a quarter of older patients deemed too frail for chemo responded to atezolizumab
ASCO: ‘Liquid Biopsy’ Shows Promise for Tumor Surveillance
Guardant360 predicts cancer DNA mutations and could help tailor treatments to avoid drug resistance
ASCO: IMAB362 Can Lengthen Lives of Gastric Cancer Patients
Patients with advanced disease lived longer when they received this targeted treatment
